Showing results (1-10 of 159) with videos related to
Sort By:
Pageof 16
The Journal of Antimicrobial Chemotherapy|April 8, 2011
Is cefepime safe for clinical use? A Bayesian viewpointAndre C KalilPlos One|May 30, 2008
Why are clinicians not embracing the results from pivotal clinical trials in severe sepsis? A bayesian analysisAndre C Kalil, Junfeng SunCritical Care Medicine|September 17, 2014
Bayesian methodology for the design and interpretation of clinical trials in critical care medicine: a primer for cliniciansAndre C Kalil, Junfeng SunIntensive Care Medicine|January 19, 2011
Low-dose steroids for septic shock and severe sepsis: the use of Bayesian statistics to resolve clinical trial controversiesAndre C Kalil, Junfeng SunCurrent Opinion in Critical Care|August 5, 2017
Pneumonia with bacterial and viral coinfectionKelly Cawcutt, Andre C KalilIntensive Care Medicine|May 28, 2008
How many patients with severe sepsis are needed to confirm the efficacy of drotrecogin alfa activated? A Bayesian designAndre C Kalil, Junfeng SunCurrent Infectious Disease Reports|June 21, 2015
Ventilator-Associated Pneumonia (VAP) with Multidrug-Resistant (MDR) Pathogens: Optimal Treatment?Kristina L Bailey, Andre C KalilCritical Care (London, England)|April 5, 2011
Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis?Andre C Kalil, Diana F FlorescuCurrent Opinion in Critical Care|July 1, 2006
L-Arginine supplementation in sepsis: beneficial or harmful?Andre C Kalil, Robert L DannerClinics in Chest Medicine|November 5, 2018
Management of Ventilator-Associated Pneumonia: GuidelinesMark L Metersky, Andre C KalilPageof 16